GluN2A(D731N) reduces the agonist potency. by Kai Gao (120150)

Subjects:

Exposure to glucocorticoids decreases the levels of pAMPK and GR in cultured rat prefrontal cortical astrocytes. by Shi-Ying Yuan (2937669)

Cell cycle progression of hMSCs following X-rays irradiation, under normoxia (21% O2) and physioxia (3% O2) growing conditions. by Séverine Cruet-Hennequart (716700)

Subjects:

Percentage decrease in model output peak with the administration of exogenous estrogen/progesterone. by Brenda Lyn A. Gavina (15285185)

S2 Data - by Dwight D. Harris (14484648)

“…Trichrome stain demonstrated a significant decrease in perivascular and interstitial fibrosis in the SIT group relative to CON (all p<0.05). …”

ASO treatment suppresses the palbociclib-mediated induction of MEG3 and decrease in cell proliferation in SK-MES-1 cells. by Traci L. Kruer (3342425)

Cisplatin treatment triggered a decrease in PTEN levels and subsequent phosphorylation of key proteins in the PTEN/Akt/FOXO3 pathway. by Eun Mi Chang (837213)

R₇-fused peptides inhibit FMDV production in BHK-21 cells. by Mónica González-Magaldi (638526)

Prolonged starvation leads to a delay in cell cycle re-entry and decrease in H3K27ac in Vasa2+/Piwi1+ cells. by Eudald Pascual-Carreras (12115380)

“…Significance levels after one-way ANOVA with Tukey’s HSD for pairwise comparisons are indicated for adjusted <i>p</i> values: *<i>p < </i>0.05, **<i>p < </i>0.01; ****<i>p < </i>0.0001. d: day(s), n.s.: non-significant. See <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003525#pbio.3003525.s016" target="_blank">S5</a> and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003525#pbio.3003525.s017" target="_blank">S6 Tables</a> for mean values and statistical data and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3003525#pbio.3003525.s020" target="_blank">S1 Data</a> for individual numerical values.…”

Table_1_A phased intervention bundle to decrease the mortality of patients with extracorporeal membrane oxygenation in intensive care unit.pdf by Yajun Jing (11711139)

“…The mean (SD) APECHII score was 24.1 (7.5). Overall, the mortality of ECMO decreased from 57.1% at baseline to 21.8% at 13–18 months after implementation of the study intervention (P < 0.001). …”

Increasing the stimulus intensity, i.e. the number of spikes in a volley, decreases axonal transmission times and the latency of stimulus response. by Helmut Schmidt (248902)

Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells - Fig 5 by Tadeja Kuret (5059433)

A functional PSA mimetic peptide (fPSA) prevents glutamate-induced MAP-2 decrease and concomitant changes in SYN and NCAM synaptic patterns and levels. by María Fernanda Podestá (639243)

“…(A) Microphotographs of hippocampal neurons in culture stained for MAP-2. …”

Variants enriched in an <i>Ae</i>. <i>aegypti</i> cell line <i>(</i>Aag2) have increased fitness in Aag2 cells but decreased fitness in a human cell line (MRC-5). by Chelsea Cereghino (15188341)

Transcriptional repression of synapse-related genes and a decrease in spine density by AAV-hGATA1 and AAV-hGATA2 in DG of the rat hippocampus. by Miyeon Choi (648726)

“…(g) Representative images are shown of high-magnification Z-stack projections of apical tuft segments of GFP(+) DG granule cells from AAV-ctl, AAV-hGATA1 and AAV-hGATA2-injected rats. (h) Density of dendritic spines (arrowheads) was significantly decreased in AAV-hGATA1- and AAV-hGATA2-injected rats compared with AAV-ctl-injected rats (a main effect of virus, <i>F</i>_2,13 = 12.9, <i>P</i><0.0001; AAV-hGATA1: <i>F</i>_1,10 = 21.15, <i>P</i> = 0.0009; AAV-hGATA2: <i>F</i>_1,7 = 5.63, <i>P</i> = 0.04). …”

Viability of hMSCs following X-rays irradiation, under normoxia (21% O₂) and physioxia (3% O₂) growing conditions. by Séverine Cruet-Hennequart (716700)

Subjects:

nsP4-C483Y or Q192L mutations decrease sensitivity to 4′-FlU. by Peiqi Yin (6533747)

Decreased MUFA/SFA ratio in total lipids of lung cancer cells treated with a small molecule inhibitor of SCD activity. by Natalia Scaglia (370865)

OSU-HDAC-44 decreased RhoA activity via srGAP1 induction, leading to F-actin dysregulation. by Yen-An Tang (187547)

“…<p>(<b>A</b>) Chromatin-immunoprecipitation-PCR analyses confirmed that treatment with 2.5 µM OSU-HDAC-44 for 2 h induced acetylation of histone H3 (H3K9K14Ac) in the promoter region of <i>srGAP1</i>, <i>NR4A1</i> and <i>FOXO4</i> genes. …”

Investigating the shared genetics of non-syndromic cleft lip/palate and facial morphology by Laurence J. Howe (5579186)

Subjects: